Neuland Laboratories announced that the 40th Annual General Meeting(AGM) of the company will be held on 31 July 2024.Powered by Capital Market - Live News

Neuland Laboratories announced that the Board of Directors of the Company at its meeting held on 10 May 2024, has recommended a Final dividend of Rs.14 per share (i.e.140%), subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Neuland Laboratories declined 20.09% to Rs 67.56 crore in the quarter ended March 2024 as against Rs 84.54 crore during the previous quarter ended March 2023. Sales declined 5.42% to Rs 385.01 crore in the quarter ended March 2024 as against Rs 407.07 crore during the previous quarter ended March 2023.For the full year,net profit rose 83.51% to Rs 300.08 crore in the year ended March 2024 as against Rs 163.52 crore during the previous year ended March 2023. Sales rose 30.84% to Rs 1558.58 crore in the year ended March 2024 as against Rs 1191.20 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales385.01407.07 -5 1558.581191.20 31 OPM %27.7729.44 -29.6822.82 - PBDT108.66123.63 -12 461.14268.52 72 PBT92.20110.16 -16 401.44215.75 86 NP67.5684.54 -20 300.08163.52 84 Powered by Capital Market - Live News

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 10 May 2024.Powered by Capital Market - Live News

Net profit of Neuland Laboratories rose 166.42% to Rs 81.39 crore in the quarter ended December 2023 as against Rs 30.55 crore during the previous quarter ended December 2022. Sales rose 45.90% to Rs 392.83 crore in the quarter ended December 2023 as against Rs 269.25 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales392.83269.25 46 OPM %30.8720.09 - PBDT119.6252.27 129 PBT104.4838.94 168 NP81.3930.55 166 Powered by Capital Market - Live News